Valuation: GSK plc

Market Cap 75.75B 103B 88.5B 82.86B 143B 9,884B 144B 980B 381B 4,964B 387B 379B 16,432B P/E 2026 *
14.3x
P/E 2027 * 11.7x
Enterprise Value 95.59B 130B 112B 105B 180B 12,472B 182B 1,237B 480B 6,264B 489B 479B 20,735B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.61x
Free-Float
92.75%
Yield 2026 *
3.68%
Yield 2027 * 3.96%
1 day-1.46%
1 week+4.02%
Current month-2.12%
1 month-0.79%
3 months-1.28%
6 months-14.30%
Current year+3.62%
1 week 1,851
Extreme 1851
1,937
1 month 1,803
Extreme 1803
2,096
Current year 1,690
Extreme 1690
2,282
1 year 1,440.29
Extreme 1440.2896
2,282
3 years 1,242.5
Extreme 1242.5
2,282
5 years 1,242.5
Extreme 1242.5
3,408.16
10 years 1,242.5
Extreme 1242.5
3,408.16
Manager TitleAgeSince
Chief Executive Officer 52 2025-12-31
Director of Finance/CFO 64 2023-04-30
Compliance Officer - 2018-07-31
Director TitleAgeSince
Director/Board Member 52 2026-05-05
Director/Board Member 64 2017-12-31
Chairman 67 2019-08-31
Date Insider Type Main position Quantity % Market Cap.
7/29/26 Sell

Executive/Senior Manager

-38,000 0.0009%
7/22/26 Buy

Executive/Senior Manager

9 0.0000%
7/14/26 Buy

Chief Technology Officer

660 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.46%+4.02%+27.78%+38.52% 105B
-0.67%+5.66%+75.21%+125.34% 1,119B
+1.04%+4.87%+52.29%+65.95% 651B
-0.17%+6.04%+25.60%+79.85% 468B
-1.38%+4.31%+41.64%+41.08% 374B
-0.52%+3.53%+24.32%+40.27% 302B
-1.06%+5.67%+1.19%+12.44% 259B
+1.03%+6.90%+51.11%+72.46% 238B
-0.53%+1.54%-17.77%-54.10% 208B
+0.42%+6.06%+27.86%+90.47% 181B
Average -0.32%+5.21%+30.92%+51.23% 390.46B
Weighted average by Cap. -0.12%+5.40%+43.50%+71.13%

Financials

2026 *2027 *
Net sales 33.94B 46.27B 39.65B 37.12B 64.04B 4,428B 64.7B 439B 170B 2,224B 174B 170B 7,361B 35.52B 48.42B 41.49B 38.85B 67.02B 4,634B 67.71B 460B 178B 2,327B 182B 178B 7,704B
Net income 5.44B 7.41B 6.35B 5.95B 10.26B 709B 10.36B 70.34B 27.31B 356B 27.8B 27.21B 1,179B 6.48B 8.84B 7.58B 7.09B 12.24B 846B 12.36B 83.91B 32.58B 425B 33.16B 32.46B 1,407B
Net Debt 19.84B 27.05B 23.18B 21.7B 37.44B 2,588B 37.82B 257B 99.67B 1,300B 101B 99.32B 4,303B 17.06B 23.26B 19.93B 18.66B 32.19B 2,226B 32.53B 221B 85.71B 1,118B 87.25B 85.41B 3,701B
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841
Date Price Change Volume
26-08-24 GBX 1,890.50 -1.46% 4,927,193
26-08-21 GBX 1,918.50 -0.10% 4,820,018
26-08-20 GBX 1,920.50 +0.23% 8,381,344
26-08-19 GBX 1,916.00 +1.48% 4,490,573
26-08-18 GBX 1,888.00 +1.97% 3,706,955
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
18.90GBP
Average target price
21.69GBP
Spread / Average Target
+14.72%

Quarterly revenue - Rate of surprise